Natus Medical Inc. (NASDAQ:BABY)’s share price dropped 2.7% during mid-day trading on Wednesday . The company traded as low as $37.25 and last traded at $37.65, with a volume of 216,424 shares traded. The stock had previously closed at $38.71.

BABY has been the topic of a number of recent research reports. Zacks Investment Research upgraded Natus Medical from a “hold” rating to a “buy” rating and set a $44.00 target price on the stock in a report on Thursday, July 7th. Roth Capital reiterated a “buy” rating on shares of Natus Medical in a report on Thursday, April 21st.

The company has a market cap of $1.23 billion and a price-to-earnings ratio of 32.74. The firm’s 50-day moving average is $39.08 and its 200 day moving average is $35.72.

Natus Medical (NASDAQ:BABY) last announced its quarterly earnings data on Wednesday, July 20th. The company reported $0.39 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.36 by $0.03. During the same quarter in the previous year, the firm posted $0.34 EPS. The company earned $96 million during the quarter, compared to the consensus estimate of $92.71 million. The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. On average, equities analysts anticipate that Natus Medical Inc. will post $1.68 earnings per share for the current year.

A number of hedge funds recently made changes to their positions in BABY. Morgan Stanley increased its stake in shares of Natus Medical by 108.0% in the fourth quarter. Morgan Stanley now owns 242,583 shares of the company’s stock valued at $11,656,000 after buying an additional 125,964 shares during the last quarter. Bank of Montreal Can increased its stake in shares of Natus Medical by 438.3% in the fourth quarter. Bank of Montreal Can now owns 66,692 shares of the company’s stock valued at $3,205,000 after buying an additional 54,303 shares during the last quarter. Finally, Wells Fargo & Company MN increased its stake in shares of Natus Medical by 533.8% in the fourth quarter. Wells Fargo & Company MN now owns 406,530 shares of the company’s stock valued at $19,534,000 after buying an additional 342,390 shares during the last quarter.

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.